Your browser doesn't support javascript.
Shoulder injury following COVID-19 vaccine administration: a case series and proposed diagnostic algorithm.
Petrakis, Nikki; Addison, Mel; Penak, Bianca; Schrader, Silja; Mallard, John; Clothier, Hazel J; Buttery, Jim P; Crawford, Nigel W; Cheng, Daryl R.
  • Petrakis N; SAEFVIC, Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, Parkville, Australia.
  • Addison M; The Royal Children's Hospital Melbourne, Parkville, Australia.
  • Penak B; SAEFVIC, Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, Parkville, Australia.
  • Schrader S; The Royal Children's Hospital Melbourne, Parkville, Australia.
  • Mallard J; The Royal Children's Hospital Melbourne, Parkville, Australia.
  • Clothier HJ; SAEFVIC, Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, Parkville, Australia.
  • Buttery JP; SAEFVIC, Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, Parkville, Australia.
  • Crawford NW; Centre for Health Analytics, Melbourne Children's Campus, Parkville, Australia.
  • Cheng DR; SAEFVIC, Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, Parkville, Australia.
Expert Rev Vaccines ; 22(1): 299-306, 2023.
Article in English | MEDLINE | ID: covidwho-2276313
ABSTRACT

BACKGROUND:

Shoulder Injury Related to Vaccine Administration (SIRVA) is a preventable adverse event following incorrect vaccine administration, which can result in significant long-term morbidity. There has been a notable surge in reported cases of SIRVA as a rapid national population-based COVID-19 immunization program has been rolled out across Australia.

METHODS:

Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC) in Victoria identified 221 suspected cases of SIRVA following the commencement of the COVID-19 vaccination program, reported between February 2021 and February 2022. This review describes the clinical features and outcomes of SIRVA in this population. Additionally, a suggested diagnostic algorithm is proposed, in order to facilitate early recognition and management of SIRVA.

RESULTS:

151 cases were confirmed as SIRVA, with 49.0% having received vaccines at state vaccination centers. 75.5% were suspected incorrect administration site, with most patients experiencing shoulder pain and restricted movement within 24 hours of vaccination, lasting on average 3 months.

CONCLUSION:

Improved awareness and education regarding SIRVA is imperative in a pandemic vaccine roll-out. The development of a structured framework for evaluating and managing suspected SIRVA will aid in timely diagnosis and treatment, essential to mitigate potential long-term complications.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Shoulder Injuries / COVID-19 Vaccines / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Oceania Language: English Journal: Expert Rev Vaccines Journal subject: Allergy and Immunology Year: 2023 Document Type: Article Affiliation country: 14760584.2023.2189463

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Shoulder Injuries / COVID-19 Vaccines / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Oceania Language: English Journal: Expert Rev Vaccines Journal subject: Allergy and Immunology Year: 2023 Document Type: Article Affiliation country: 14760584.2023.2189463